Infantile hemangioma (IH) is a common tumor in infants. After the proliferative phase, hemangiomas regress, but sometimes leave scars. Propranolol is now the recommended first-line oral therapy for IH. To evaluate the...
1普萘洛尔多次给药治疗婴幼儿血管瘤的心血管状况分析 Cardiovascular profile of propranolol after multiple dosing in infantile hemangioma. Salice P, Giovanni Bianchetti M, Giavarini A, et al. Pharmacology, 2016,99(1-2)...
3口服普纳洛尔治疗婴幼儿血管瘤的安全性:系统回顾 Safety of oral propranolol for the treatment of infantile hemangioma: a systematic review. Leaute- Labreze C, Boccara O, Degrugillier-Chopinet C, et al. Pediatrics, 201...
AIM: To analyze the evolution in the management of airway infantile hemangioma(AIH) and to report the results from 3 pediatric tertiary care institutions.METHODS: A retrospective study of patients with diagnosis of AI...
Infantile hemangioma(IH) is the most common benign tumor seen in infancy. This review provides up-to-date information on the pathophysiology, variations in clinical presentation, and natural history of IH, elaborating...
Background: Infantile haemangioma is the commonest childhood tumor. Several lines of treatment are available. Recent reports have focused on the value of propranolol in treating rapidly proliferating haemangioma. The ...
1普萘洛尔有效治疗消退期婴幼儿血管瘤
Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase.Vivas-Colmenares GV,Bernabeu-Wittel J,AlonsoArroyo V,et al.Pediatr Dermatol,201...
6 血管瘤患儿普萘洛尔治疗前的心脏检查
Cardiac screening in infants with infantile hemangiomas before propranolol treatment. Blei F, McElhinney DB, Guarini A, et al. Pediatr Dermatol, 2014 May 29.
普萘洛尔治疗婴幼儿...